CHELATEC

AGINKO Research is the premiere CRO for preclinical work in osteoarticular pathologies. We offer a wide range of contract research services to support Drug and Medical Device established companies as well as start-ups and academia. From industry standard protocols to customized research design, our animal models and assays, both on an in vivo or in vitro basis, provide key tools for compound discovery and product development.

Given our expertise, know-how, and network in the field of osteoarticular pathologies, AGINKO today also offers a full range of histology services for your preclinical and clinical trials as well as general consulting services (e.g., regulatory, strategy, financing) devoted to osteoarticular pathologies.


#Osteoarticular #CRO #Cartilage #Repair #Arthritis #Fracture #Osteoporosis #Preclinical #Pain #Disc #Spine #Infection

BioCentrum's mission is to create a platform for our clients and partners in order to help them translate innovative discoveries into preclinical candidates with improved chances to become marketed in the least amount of time possible. Our offer is a range of in vitro and in vivo assays that are created toward incorporating preclinical information into your pipeline.

We provide world-class analytical instruments and services for validating, selecting and optimizing drug candidates. For our track record of 75+ analyzed candidates we have so far improved the overall clinical trial success rate by more than 4x. By accurately classifying candidates prior to clinical trials, we allow pharmaceutical companies to focus on the most promising candidates, increasing their efficiency and profitability.

Attana was founded with the vision of in vitro characterization of molecular interactions, mimicking in vivo conditions. We have developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. We are also developing the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool, for e.g. SARS-CoV-2 testing and immunity profiling.

To learn more about our latest services and products, please visit www.attana.com or contact info@attana.com.

There are several GLP-compliant non-clinical CRO’s. Why choose the Aurigon Group?
• We're big enough to provide a full service, but small enough to fully adapt to your needs
• Our qualified staff consists of 70+ professionals, with even 30+ years of experience
• Our proven track record of more than 5700 studies gives us a solid base to serve your needs
• Our flexible approach and your direct contact to the Study Director gives you full control of your study

Aurigon offers a full range of in vivo and in vitro non-clinical services from development candidate to marketed product. These services include, but are not limited to: PK/PD, ADME, bioanalytics, toxicology and safety pharmacology in all species used in toxicity testing ranging from mouse to minipig.

For our clients we provide tailor-made services on a variety of test item classes including NCE, NBE, herbal extracts, vaccines, medical devices to name a few. We intend to build up long-term partnerships by acting as a problem-solver in our partners’ projects; keeping their budget, timeline and goals in mind.

Aurigon shares its expert knowledge and performs GxP training services (GLP, GMP for batch release assays, GcLP). Our clients will benefit from our comprehensive experience and get new insight into the GxP regulated environment.

As Central European Center for Minipig Research we possess a spacious site as well as sound professional experience for minipig testing. This is accompanied by facilities for small and large animal testing (rodents, rabbits, dogs, ...) as well as in vitro laboratories close to the city borders of Budapest. Furthermore, we maintain a well-equipped bioanalytical department in Budapest.

For more detailed information about our broad service portfolio you may also visit our website (www.aurigon.eu).

Get in touch and let us foster your project a wing stroke ahead!

Studies are performed by our sister company, ATRC Aurigon Toxicological Research Center Ltd.

Cardiomedex is a highly skilled preclinical CRO specialized in the cardiovascular field. Cardiomedex conducts reliable studies that optimize the preclinical development of drug candidates for the treatment of cardiovascular diseases and cardiometabolic complications.

Our large selection of gold standard animal models covers cardiovascular disorders such as:

Heart failure with preserved or reduced ejection fraction
Myocardial infarction
Cardiac hypertrophy
Hypertension
Endothelial dysfunction
Anthracycline cardiotoxicity

Along with in vivo models, we offer a state-of-the-art platform for functional exploration & pharmacological characterization using ex-vivo and in vitro assays.

In addition to CRO services, we provide our clients with personalized consulting services in line with the pharma industry’s emerging trends.